These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9876820)

  • 21. Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis.
    Jia Z; Lu H; Yang X; Jin X; Wu R; Zhao J; Chen L; Qi Z
    Aesthetic Plast Surg; 2016 Oct; 40(5):769-77. PubMed ID: 27495260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective open-label study of botulinum toxin type B (Myobloc) at doses of 2,400 and 3,000 U for the treatment of glabellar wrinkles.
    Sadick NS
    Dermatol Surg; 2003 May; 29(5):501-7; discussion 507. PubMed ID: 12752518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin in facial rejuvenation: an update.
    Carruthers J; Carruthers A
    Dermatol Clin; 2009 Oct; 27(4):417-25, v. PubMed ID: 19850191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type B for dynamic glabellar rhytides refractory to botulinum toxin type A.
    Alster TS; Lupton JR
    Dermatol Surg; 2003 May; 29(5):516-8. PubMed ID: 12752520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of botulinum toxin: an application to blepharospasm Schwartz-Jampel syndrome.
    Vargel I; Canter HI; Topaloglu H; Erk Y
    J Craniofac Surg; 2006 Jul; 17(4):656-60. PubMed ID: 16877909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxins for facial wrinkles: beyond glabellar lines.
    Dayan SH; Maas CS
    Facial Plast Surg Clin North Am; 2007 Feb; 15(1):41-9, vi. PubMed ID: 17317554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. OnabotulinumtoxinA treatment of mild glabellar lines in repose.
    Carruthers A; Carruthers J; Lei X; Pogoda JM; Eadie N; Brin MF
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2168-71. PubMed ID: 21134048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eyebrow height after botulinum toxin type A to the glabella.
    Carruthers A; Carruthers J
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S26-31. PubMed ID: 17241411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current and future botulinum neurotoxin type A preparations in aesthetics: a literature review.
    Sattler G
    J Drugs Dermatol; 2010 Sep; 9(9):1065-71. PubMed ID: 20865836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dilution, storage, and electromyographic guidance in the use of botulinum toxins.
    Mantell AM
    Dermatol Clin; 2004 Apr; 22(2):135-6, v. PubMed ID: 15222572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines.
    Carruthers JD; Lowe NJ; Menter MA; Gibson J; Eadie N;
    Plast Reconstr Surg; 2003 Sep; 112(4):1089-98. PubMed ID: 12973229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-finding, safety, and tolerability study of botulinum toxin type B for the treatment of hyperfunctional glabellar lines.
    Carruthers A; Carruthers J; Flynn TC; Leong MS
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S60-8. PubMed ID: 17241416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin A: its expanding role in dermatology and esthetics.
    Said S; Meshkinpour A; Carruthers A; Carruthers J
    Am J Clin Dermatol; 2003; 4(9):609-16. PubMed ID: 12926979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of anal fissures with botulinum toxin].
    Wollina U
    Zentralbl Chir; 2008 Apr; 133(2):123-8. PubMed ID: 18415898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin for the treatment of major depressive disorder].
    Hawlik AE; Freudenmann RW; Pinkhardt EH; Schönfeldt-Lecuona CJ; Gahr M
    Fortschr Neurol Psychiatr; 2014 Feb; 82(2):93-9. PubMed ID: 24519192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A.
    Solish N; Carruthers J; Kaufman J; Rubio RG; Gross TM; Gallagher CJ
    Drugs; 2021 Dec; 81(18):2091-2101. PubMed ID: 34787840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vivo analysis of the effect and duration of treatment with botulinum toxin type A using digital image speckle correlation.
    Bhatnagar D; Conkling N; Rafailovich M; Phillips BT; Bui DT; Khan SU; Dagum AB
    Skin Res Technol; 2013 Aug; 19(3):220-9. PubMed ID: 23565582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and complications of a new technique of Abobotulinum-toxin A (Dysport) injection in patients with glabellar lines.
    Karbassi E; Nakhaee N; Zamanian M
    J Cosmet Dermatol; 2019 Feb; 18(1):55-58. PubMed ID: 29569830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New indications for botulinum toxin type A in treating facial wrinkles of the mouth and neck.
    Spósito MM
    Aesthetic Plast Surg; 2002; 26(2):89-98. PubMed ID: 12016492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.